Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3

Xiaoyu Wan1, Jiajun Yap1,2, Junjun Chen1

  • 1The Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore General Hospital, 30 Hospital Boulevard, Singapore 168583.

Theranostics
|February 3, 2025
PubMed

Insights

Non-V600 BRAF mutations disrupt RAF protein regulation by Cdc37/Hsp90 chaperones and 14-3-3 scaffolds, trapping RAF in active dimers. These oncogenic RAF dimers can be targeted by specific RAF dimer breakers.

Area of Science:

  • Molecular Cell Biology
  • Cancer Biology
  • Protein Regulation

Background:

  • RAF kinases, especially BRAF, are frequent oncogenic targets in cancer.
  • Mechanisms by which non-V600 BRAF mutations promote oncogenicity are not fully understood.
  • RAF protein function is regulated by Cdc37/Hsp90 chaperones and 14-3-3 scaffolds.

Purpose of the Study:

  • To investigate how Cdc37/Hsp90 chaperones and 14-3-3 scaffolds regulate RAF protein function.
  • To elucidate how non-V600 BRAF mutations evade this regulatory machinery.

Main Methods:

  • Utilized mutagenesis, peptide affinity assays, immunoprecipitation, and immunoblotting.
  • Employed complementary split luciferase assays and a mouse xenograft tumor model.
  • Investigated the interaction between RAF proteins, Cdc37/Hsp90, and 14-3-3 scaffolds.

Main Results:

  • Cdc37/Hsp90 and 14-3-3 promote the switch of BRAF from active dimers to inactive monomers.
  • Non-V600 mutations impair Cdc37/Hsp90 binding, trapping BRAF in active, dimerized conformations.
  • These BRAF mutants and mature CRAF/ARAF dimers sustain prolonged ERK signaling and respond to RAF dimer breakers.

Conclusions:

  • Cdc37/Hsp90 chaperones and 14-3-3 scaffolds are crucial for RAF inactivation.
  • Non-V600 BRAF mutations disrupt this regulation, leading to persistent RAF dimerization and signaling.
  • Targeting these RAF dimers with specific inhibitors represents a potential therapeutic strategy.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K